Home / GLAND.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does GLAND.NS make money? Does GLAND.NS have pricing power? What's the Earnings Whisper? Will GLAND.NS profit more as the business scales? What is GLAND.NS's management track record? Is GLAND.NS's current price justified?

Gland Pharma Limited

₹3043.4 +$1328.30 (+77.45%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹3066.3

Day Range

₹3004.3₹3096.9

Year Range

₹1573.6₹3171

Market Cap

502.19B

AVG Volume

665.88K

Trailing/Forward PE

44.42/30.84

PEG ratio

1.14

Dividend Yield

0.66%

Next Earnings Date

2026-11-06

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

GLAND.NS Revenue (INR) by year
Period	Revenue (INR)
2026	64.31B
2025	56.17B
2024	56.65B
2023	36.25B
2022	44.01B
2021	34.63B

Net Income (INR) · A

GLAND.NS Net Income (INR) by year
Period	Net Income (INR)
2026	10.27B
2025	6.99B
2024	7.72B
2023	7.81B
2022	12.12B
2021	9.97B

Operating Income (INR) · A

GLAND.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	12.06B
2025	14.54B
2024	15.55B
2023	11.57B
2022	15.84B
2021	14.33B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Gland Pharma Limited

Video analysis: GLAND.NS

News: GLAND.NS

Similar companies